PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 25 filers reported holding PSYCHEMEDICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $138 | -9.8% | 35 | +2.9% | 0.00% | – |
Q2 2023 | $153 | -11.6% | 34 | +6.2% | 0.00% | – |
Q1 2023 | $173 | +10.2% | 32 | 0.0% | 0.00% | – |
Q4 2022 | $157 | – | 32 | +6.7% | 0.00% | – |
Q3 2022 | $0 | – | 30 | -9.1% | 0.00% | – |
Q2 2022 | $0 | – | 33 | +10.0% | 0.00% | – |
Q1 2022 | $0 | – | 30 | 0.0% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 30 | -89.5% | 0.00% | – |
Q3 2021 | $2,000 | – | 287 | +744.1% | 0.00% | – |
Q2 2021 | $0 | – | 34 | 0.0% | 0.00% | – |
Q1 2021 | $0 | -100.0% | 34 | -98.6% | 0.00% | – |
Q4 2020 | $13,000 | -70.5% | 2,432 | -75.7% | 0.00% | – |
Q3 2020 | $44,000 | -44.3% | 10,004 | -30.1% | 0.00% | – |
Q2 2020 | $79,000 | -21.8% | 14,314 | -14.5% | 0.00% | – |
Q1 2020 | $101,000 | -41.6% | 16,745 | -11.8% | 0.00% | – |
Q4 2019 | $173,000 | -21.7% | 18,980 | -22.0% | 0.00% | – |
Q3 2019 | $221,000 | -4.7% | 24,345 | +6.2% | 0.00% | – |
Q2 2019 | $232,000 | +74.4% | 22,924 | +140.6% | 0.00% | – |
Q1 2019 | $133,000 | +54.7% | 9,526 | +74.9% | 0.00% | – |
Q4 2018 | $86,000 | -11.3% | 5,445 | +5.6% | 0.00% | – |
Q3 2018 | $97,000 | -26.0% | 5,154 | -24.2% | 0.00% | – |
Q2 2018 | $131,000 | -12.1% | 6,800 | -2.4% | 0.00% | – |
Q1 2018 | $149,000 | +3.5% | 6,967 | -0.6% | 0.00% | – |
Q4 2017 | $144,000 | +161.8% | 7,008 | +136.1% | 0.00% | – |
Q3 2017 | $55,000 | +120.0% | 2,968 | +196.5% | 0.00% | – |
Q2 2017 | $25,000 | -16.7% | 1,001 | -33.3% | 0.00% | – |
Q1 2017 | $30,000 | – | 1,501 | – | 0.00% | – |
Q4 2016 | $0 | – | 0 | – | 0.00% | – |
Q3 2016 | $0 | – | 0 | -100.0% | 0.00% | – |
Q2 2016 | $0 | – | 1 | 0.0% | 0.00% | – |
Q1 2016 | $0 | – | 1 | – | 0.00% | – |
Q4 2015 | $0 | – | 0 | -100.0% | 0.00% | – |
Q3 2015 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
Q2 2015 | $318,000 | +5.3% | 21,442 | +17.7% | 0.00% | – |
Q1 2015 | $302,000 | – | 18,222 | – | 0.00% | – |
Q4 2014 | $0 | – | 0 | – | 0.00% | – |
Q3 2014 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q2 2014 | $26,000 | -13.3% | 1,805 | +2.7% | 0.00% | – |
Q1 2014 | $30,000 | – | 1,758 | – | 0.00% | – |
Q4 2013 | $0 | – | 0 | -100.0% | 0.00% | – |
Q3 2013 | $0 | – | 1 | 0.0% | 0.00% | – |
Q2 2013 | $0 | – | 1 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WEALTH EFFECTS LLC | 40,001 | $276,000 | 0.13% |
SANTA MONICA PARTNERS LP | 20,000 | $138,000 | 0.10% |
Invenomic Capital Management LP | 135,631 | $769,000 | 0.08% |
Cannell Capital | 78,306 | $540,000 | 0.08% |
RBF Capital, LLC | 144,231 | $996,000 | 0.06% |
CRAWFORD INVESTMENT COUNSEL INC | 266,502 | $1,839,000 | 0.04% |
Ancora Advisors LLC | 80,728 | $557,000 | 0.01% |
HighMark Wealth Management LLC | 2,039 | $14,000 | 0.01% |
Renaissance Technologies | 341,422 | $2,356,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 34,618 | $240,000 | 0.00% |